Skip to main content
Top
Published in: Journal of Nuclear Cardiology 6/2021

01-12-2021 | Positron Emission Tomography | EDITORIAL

How viable is SPECT for viability assessment in the PET era?

Authors: Pavithra S. Jayadeva, MBBS, Nathan Better, MBBS, FRACP, FASNC

Published in: Journal of Nuclear Cardiology | Issue 6/2021

Login to get access

Excerpt

The article published by Zhang et al has entertained a novel assessment of myocardial viability with the integration of myocardial perfusion, wall motion and thickening with SPECT as a valid alternative to conventional PET imaging. In patients with ischemic heart failure, the ability to assess viable myocardium has been a cornerstone to assess cardiac status and potentially alter outcomes in patients with reduced left ventricular function. Patients with dysfunctional but viable myocardium have historically benefited from revascularization.1 Hibernation is a phase best described as viable myocardium existing in a transitional state with recurrent ischemic triggers rendering the myocardium dysfunctional, but still in possession of the metabolic capacity to contribute to contractile reserve following revascularization.2
Literature
1.
go back to reference Klein C, Nekolla SG, Bengel FM, et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002;105:162-7.CrossRef Klein C, Nekolla SG, Bengel FM, et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002;105:162-7.CrossRef
2.
go back to reference Braunwald E, Kloner R. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-9.CrossRef Braunwald E, Kloner R. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-9.CrossRef
3.
go back to reference Pagley P, Beller G, Watson D, Gimple L, Ragosta M. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997;96. Pagley P, Beller G, Watson D, Gimple L, Ragosta M. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997;96.
4.
go back to reference Gewirtz H, Dilsizian V. Myocardial viability: survival mechanisms and molecular imaging targets in acute and chronic ischemia. Circ Res 2017;120:1197-212.CrossRef Gewirtz H, Dilsizian V. Myocardial viability: survival mechanisms and molecular imaging targets in acute and chronic ischemia. Circ Res 2017;120:1197-212.CrossRef
5.
go back to reference Maruyama A, Hasegawa S, Paul AK, et al. Myocardial viability assessment with gated SPECT Tc-99m tetrofosmin % wall thickening: comparison with F-18 FDG-PET. Ann Nucl Med 2002;16:25-32.CrossRef Maruyama A, Hasegawa S, Paul AK, et al. Myocardial viability assessment with gated SPECT Tc-99m tetrofosmin % wall thickening: comparison with F-18 FDG-PET. Ann Nucl Med 2002;16:25-32.CrossRef
6.
go back to reference Beanlands RS, Nichol G, Huszti E, et al. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol 2007;50:2002-12.CrossRef Beanlands RS, Nichol G, Huszti E, et al. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol 2007;50:2002-12.CrossRef
7.
go back to reference Mc Ardle B, Shukla T, Nichol G, et al. Long-term follow-up of outcomes with F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction secondary to coronary disease. Circ Cardiovasc Imaging 2016;9. Mc Ardle B, Shukla T, Nichol G, et al. Long-term follow-up of outcomes with F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction secondary to coronary disease. Circ Cardiovasc Imaging 2016;9.
8.
go back to reference Afridi I, Quinones MA, Zoghbi WA, Cheirif J. Dobutamine stress echocardiography: sensitivity, specificity, and predictive value for future cardiac events. Am Heart J 1994;127:1510-5.CrossRef Afridi I, Quinones MA, Zoghbi WA, Cheirif J. Dobutamine stress echocardiography: sensitivity, specificity, and predictive value for future cardiac events. Am Heart J 1994;127:1510-5.CrossRef
9.
go back to reference Bax JJ, Poldermans D, Elhendy A, Boersma E, Rahimtoola SH. Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 2001;26:147-86.CrossRef Bax JJ, Poldermans D, Elhendy A, Boersma E, Rahimtoola SH. Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 2001;26:147-86.CrossRef
10.
go back to reference Bax JJ, Delgado V. Myocardial viability as integral part of the diagnostic and therapeutic approach to ischemic heart failure. J Nucl Cardiol 2015;22:229-45.CrossRef Bax JJ, Delgado V. Myocardial viability as integral part of the diagnostic and therapeutic approach to ischemic heart failure. J Nucl Cardiol 2015;22:229-45.CrossRef
11.
go back to reference Morton G, Schuster A, Perera D, Nagel E. Cardiac magnetic resonance imaging to guide complex revascularization in stable coronary artery disease. Eur Heart J 2010;31:2209-15CrossRef Morton G, Schuster A, Perera D, Nagel E. Cardiac magnetic resonance imaging to guide complex revascularization in stable coronary artery disease. Eur Heart J 2010;31:2209-15CrossRef
12.
go back to reference Sciagra R, Santoro GM, Bisi G, Pedenovi P, Fazzini PF, Pupi A. Rest-redistribution thallium-201 SPECT to detect myocardial viability. J Nucl Med 1998;39:384-90.PubMed Sciagra R, Santoro GM, Bisi G, Pedenovi P, Fazzini PF, Pupi A. Rest-redistribution thallium-201 SPECT to detect myocardial viability. J Nucl Med 1998;39:384-90.PubMed
13.
go back to reference Hunold P, Jakob H, Erbel R, Barkhausen J, Heilmaier C. Accuracy of myocardial viability imaging by cardiac MRI and PET depending on left ventricular function. World J Cardiol 2018;10:110-8.CrossRef Hunold P, Jakob H, Erbel R, Barkhausen J, Heilmaier C. Accuracy of myocardial viability imaging by cardiac MRI and PET depending on left ventricular function. World J Cardiol 2018;10:110-8.CrossRef
Metadata
Title
How viable is SPECT for viability assessment in the PET era?
Authors
Pavithra S. Jayadeva, MBBS
Nathan Better, MBBS, FRACP, FASNC
Publication date
01-12-2021
Publisher
Springer International Publishing
Published in
Journal of Nuclear Cardiology / Issue 6/2021
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-020-02084-6

Other articles of this Issue 6/2021

Journal of Nuclear Cardiology 6/2021 Go to the issue